Trials / Terminated
TerminatedNCT04643535
In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery
Glycocalyx as Predictor of Complications After Cardiac Surgery
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac surgery has been described as altering endothelium structure and function, notably because of the use of cardiac-pulmonary bypass (CPB). Among the endothelial structure, glycocalyx, the thin layer recovering the endothelial surface, may be altered by the inflammatory process and probably the modification of flow during CPB. Endothelial and glycocalyx integrity are essential for vascular function and glycocalyx destruction is associated with organ failure and mortality. On the other hand, a chronic alteration of glycocalyx is observed in many diseases such as diabetes, hypertension or chronic kidney failure, all pathologies frequently observed in patients benefiting grom cardiac surgery. Thus the preoperative alteration of glycocalyx may be associated with postoperative organ failure.
Conditions
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2024-07-03
- Completion
- 2025-12-30
- First posted
- 2020-11-25
- Last updated
- 2026-02-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04643535. Inclusion in this directory is not an endorsement.